We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Trimel Pharmaceuticals Corporation Completes Patient Enrollment of CompleoTRT Phase III Safety Cohort

News   Jan 18, 2012

 
Trimel Pharmaceuticals Corporation Completes Patient Enrollment of CompleoTRT Phase III Safety Cohort
 
 
Advertisement
 

RELATED ARTICLES

Prevalence of Coronavirus Antibodies Declining in England

News

Tests on more than 365,000 people in England have shown that the antibody response to the virus that causes COVID-19 wanes over time.

READ MORE

Trial Will Investigate if Anti-Nausea Drug Can Alleviate Hallucinations in People With Parkinson's

News

Phase 2 clinical trial will explore if the drug ondansetron is safe and effective against hallucinations in patients with Parkinson's disease.

READ MORE

Heart–Breast Cancer-on-a-Chip Developed To Monitor Cardiac Toxicity Arising From Chemo

News

Researchers have developed an organ-on-a-chip system that more widely examines the responses of breast cancer and heart tissues to breast cancer drugs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE